Overland Park, KS2 Active Studies

Interstitial Cystitis Clinical Trials in Overland Park, KS

Find 2 actively recruiting interstitial cystitis clinical trials in Overland Park, KS. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
953
Enrolling

Recruiting Interstitial Cystitis Studies in Overland Park

About Interstitial Cystitis Clinical Trials in Overland Park

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 2 interstitial cystitis clinical trials recruiting participants in Overland Park, KS. These studies are seeking a combined 953 participants. Research is being sponsored by Claris Biotherapeutics, Inc., Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Overland Park — FAQ

Are there interstitial cystitis clinical trials in Overland Park?

Yes, there are 2 interstitial cystitis clinical trials currently recruiting in Overland Park, KS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Overland Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Overland Park research site will contact you about next steps.

Are clinical trials in Overland Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Overland Park studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 2 active trials in Overland Park are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated August 28, 2026 from ClinicalTrials.gov